Riik: Austraalia
keel: inglise
Allikas: APVMA (Australian Pesticides and Veterinary Medicines Authority)
CLOSTRIDIUM CHAUVOEI - FORMOL CULTURE; LEPTOSPIRA INTERROGANS SEROVAR POMONA; LEPTOSPIRA BORGPETERSENII SEROVAR HARDJO; CLOSTRIDIUM NOVYI TYPE B - TOXOID; CLOSTRIDIUM PERFRINGENS TYPE D TOXOID; CLOSTRIDIUM SEPTICUM - TOXOID; CLOSTRIDIUM TETANI - TOXOID
ZOETIS AUSTRALIA PTY LTD
Cl perfringens toxoid (D)+Cl tetani - toxoid+Cl novyi type B + others
MISC. VACCINES OR ANTI SERA
CLOSTRIDIUM CHAUVOEI - FORMOL CULTURE VACCINE-MICROBIAL Active 0.0 P; LEPTOSPIRA INTERROGANS SEROVAR POMONA VACCINE-MICROBIAL Active 0.0 P; LEPTOSPIRA BORGPETERSENII SEROVAR HARDJO VACCINE-MICROBIAL Active 0.0 P; CLOSTRIDIUM NOVYI TYPE B - TOXOID VACCINE-TOXOID Active 0.0 P; CLOSTRIDIUM PERFRINGENS TYPE D TOXOID VACCINE-TOXOID Active 0.0 P; CLOSTRIDIUM SEPTICUM - TOXOID VACCINE-TOXOID Active 0.0 P; CLOSTRIDIUM TETANI - TOXOID VACCINE-TOXOID Active 0.0 P
100mL; 250mL; 500mL; 50mL
VM - Veterinary Medicine
ZOETIS AUSTRALIA
CATTLE | BEEF | BOS INDICUS | BOS TAURUS | BOVINE | BUFFALO | BULL | BULLOCK | CALF | COW | DAIRY COW | HEIFER | STEER
IMMUNOTHERAPY
BLACK DISEASE | BLACKLEG | ENTEROTOXAEMIA (PULPY KIDNEY) | LEPTOSPIROSIS | MALIGNANT OEDEMA | TETANUS | CLOSTRIDIUM PERFRINGENS TYPE D | L. HARDJO | L. INTERROGANS | L. POMONA | L. TARASSOVI | TETANUS VACCINATION
Poison schedule: 0; Withholding period: MEAT: Zero (0) days MILK: Zero (0) days Export Slaughter Interval (ESI): Zero (0) days; Host/pest details: CATTLE: [BLACK DISEASE, BLACKLEG, ENTEROTOXAEMIA (PULPY KIDNEY), LEPTOSPIROSIS, MALIGNANT OEDEMA, TETANUS]; Poison schedule: 0; Withholding period: WHP: Nil. ESI: Not Applicable; Host/pest details: CATTLE: [BLACK DISEASE, BLACKLEG, ENTEROTOXAEMIA (PULPY KIDNEY), LEPTOSPIROSIS, MALIGNANT OEDEMA, TETANUS]; Poison schedule: 0; Withholding period: ; Host/pest details: CATTLE: [BLACK DISEASE, BLACKLEG, ENTEROTOXAEMIA (PULPY KIDNEY), LEPTOSPIROSIS, MALIGNANT OEDEMA, TETANUS]; For the prevention of enterotoxaemia (pulpy kidney disease), tetanus, black disease, malignant oedema (blackleg like disease), blackleg, and leptospirosis in cattle. Prevents urinary shedding of named leptospires when used prior to natural exposure.
Registered
2023-07-01
( c APPENDIX2 Australian Government Australian Pesticides and Veterinary Medicines Authority TEMPLATE FOR RELEVANT LABEL PARTICULARS (RLPs) (Veterinary Produ~s{o Select appropriate: Cl New Product (include all applicable RLPs) OR IRl Variation (highlight instructions that are being varied). Approval no. of label being varied: 53276/1 [2,3,4]/0509 Signal heading: Product name: Active constituent/s: Statement of claims: RLP Approved Net contents: FOR ANIMAL TREATMENT ONLY Ultravac® 7 in 1 Vaccine Ct. perfringens type D;;, 5 IU/mL, Ct. tetani;;, 2.5 IU/mL, C/. novyi type B ;;,3.51U/mL, Ct. septicum ;;, 2.5 IU/mL (as ultrafiltered toxoids), Ct. chauvoei 0.3 mUmL, Leptospira interrogans serovar Pomona;;, 400x1 0 6 organisms/mL, Leptospira borgpetersenii serovar Hardjo type Hardjobovis;;, 400x 10 6 organisms/mL (as formal cultures) 0.1 mg/mL Thiomersal added as a preservative Ultravac 7in1 is used for the routine immunisation of cattle for the prevention of enterotoxaemia (pulpy kidney disease), tetanus, black disease, malignant oedema (blackleg-like disease), blackleg and leptospirosis in cattle. For the prevention of urinary shedding of the named leptospires in cattle when used prior to natural exposure and to prevent the risk of human leptospiral infection associated with the shedding of the named leptospires in the urine and from the reproductive tract of cattle. For the prevention of enterotoxaemia (pulpy kidney disease), tetanus, black disease, malignant oedema (blackleg-like disease), blackleg and leptospirosis in cattle. Prevents urinary shedding of the named leptospires when used prior to natural exposure and to prevent the risk of human leptospiral infection associated with the shedding of the named leptospires in the urine and from the reproductive tract of cattle. For the prevention of reproductive tract colonisation and placental and foetal infection with L. Hardjo. APVMA'f.Jo. 53276/60300 50mL, 100mL, 250 mL and 500 mL 18 Wormald Street, Symonston ACT 2609 PO Box 6182, Kingston ACT 2604 Australia Tel: +6 Lugege kogu dokumenti
PRODUCT NAME: ULTRAVAC ® 7 IN 1, COMBINED 5 IN 1 / LEPTO VACCINE FOR CATTLE PAGE: 1 OF 5 THIS REVISION ISSUED: APRIL, 2010 MATERIAL SAFETY DATA SHEET Issued by: Pfizer Australia Pty Ltd Phone: (02)9850 3333 SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY Pfizer Australia Pty Ltd 38-42 Wharf Road West Ryde NSW 2114 Tel: (02) 9850 3333 Fax: (02) 9850 3399 ____________________________________ PFIZER AUSTRALIA PTY LTD A.B.N. 50 008 422 348 SUBSTANCE: Water solution/suspension of bacterial toxoids. TRADE NAME: ULTRAVAC ® 7 IN 1, COMBINED 5IN1 / LEPTO VACCINE FOR CATTLE OTHER NAMES: _Cl. perfringens_ Type D, _Cl. tetani, Cl. septicum, Cl. novyi_ Type B, _Cl. chauvoei, L. _ _hardjo, L. pomona_ Vaccine for Cattle PFIZER MSDS CODE: 0087 PRODUCT USE: For the prevention of clostridial and leptospirosis diseases in cattle. CREATION DATE: DECEMBER, 2004 THIS VERSION ISSUED: APRIL, 2010 and is valid for 5 years from this date. SECTION 2 - HAZARDS IDENTIFICATION STATEMENT OF HAZARDOUS NATURE This product is classified as: Not classified as hazardous according to the criteria of SWA Australia. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: Not Hazardous - No criteria found. SUSDP CLASSIFICATION: None (Aust); S2 (NZ) ADG CLASSIFICATION: None allocated. Not a Dangerous Good. UN NUMBER: None allocated E E E M M M E E E R R R G G G E E E N N N C C C Y Y Y O O O V V V E E E R R R V V V I I I E E E W W W PHYSICAL DESCRIPTION & COLOUR : Aqueous suspension. ODOUR: No data. MAJOR HEALTH HAZARDS: no significant risk factors have been found for this product. P P P O O O T T T E E E N N N T T T I I I A A A L L L H H H E E E A A A L L L T T T H H H E E E F F F F F F E E E C C C T T T S S S INACTIVATED CULTURES AND TOXOIDS ARE NOT REGARDED AS PATHOGENIC IN HUMANS. INHALATION SHORT TERM EXPOSURE: Significant inhalation exposure is considered to be unlikely. The spray mist may be discomforting to the upper respiratory tract and lungs, and Lugege kogu dokumenti